Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Albemarle Corp

ALB:NYQ

Albemarle Corp

Actions
Basic MaterialsChemicals
  • Price (USD)116.88
  • Today's Change1.90 / 1.65%
  • Shares traded1.72m
  • 1 Year change-35.50%
  • Beta1.6643
Data delayed at least 15 minutes, as of Apr 26 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
Select bar for recommendation details.
Recommendations18-Apr-24
Buy6
Outperform11
Hold9
Underperform2
Sell0

Share price forecast in USD

The 24 analysts offering 12 month price targets for Albemarle Corporation have a median target of 145.50, with a high estimate of 216.00 and a low estimate of 81.00. The median estimate represents a 24.49% increase from the last price of 116.88.
High84.8%216.00
Med24.5%145.50
Low-30.7%81.00

Dividends in USD

In 2023, Albemarle Corp reported a dividend of 2.00 USD, which represents a 26.67% increase over last year. The 13 analysts covering the company expect dividends of 1.62 USD for the upcoming fiscal year, a decrease of 18.70%.
Div growth (TTM)26.67%
More ▼

Earnings history & estimates in USD

On Feb 14, 2024, Albemarle Corporation reported 4th quarter 2023 earnings of 1.85 per share. This result exceeded the 1.01 consensus of the 19 analysts covering the companyand under-performed last year's 4th quarter results by 78.54%.
The next earnings announcement is expected on May 01, 2024.
Average growth rate-26.09%
Albemarle Corporation reported annual 2023 earnings of 22.25 per share on Feb 14, 2024.
Average growth rate+102.79%
More ▼

Revenue history & estimates in USD

Albemarle Corporation had 4th quarter 2023 revenues of 2.36bn. This bettered the 2.18bn consensus of the 17 analysts covering the company. This was 108.92% above the prior year's 4th quarter results.
Average growth rate-2.56%
Albemarle Corporation had revenues for the full year 2023 of 9.62bn. This was 31.38% above the prior year's results.
Average growth rate+36.22%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.